This concise manual describes in detail how to perform a transcatheter aortic valve replacement (TAVR) procedure and provides cardiac surgeons and cardiologists with the foundation necessary to begin practicing TAVR. It includes background on the landmark data establishing the field of TAVR, instructions in the pre- and post-operative management of TAVR patients, and technical descriptions of the newest and most common devices and how to use them. Written by leaders in the field, it offers an unbiased, academic review and describes the experience of colleagues who have learned through trial and error. The Transcatheter Aortic Valve Replacement Manual is an essential resource for physicians and related professionals, residents, fellows, and graduate students in cardiology, cardiac surgery, thoracic surgery, and vascular surgery

Publisher's Note: Products purchased from 3rd Party sellers are not guaranteed by the Publisher for quality, authenticity, or access to any online entitlements included with the product. Launch and cultivate a successful program for the innovative procedure poised to become the standard for patients with aortic stenosis (AS) with Transcatheter Aortic Valve Replacement (TAVR) Program Development: A Guide for the Heart Team. Written by leaders in the field, this clinical instruction manual is the first to consolidate evidence, guidelines, and best practices for the TAVR care pathway from referral to follow-up. This is a must-have for clinicians—nurses, physicians, and allied health professionals—as well as administrative leadership and staff involved in TAVR programs. The text offers a comprehensive view of the TAVR program organized to support staff and quality, and positioned to grow on pace with evolving indications, regulations, technology, and patient needs.

Aortic Valve Transcatheter Intervention Calcific aortic stenosis (AS) is the most common heart valve anomaly, with a largely age-dependent prevalence, a calculated annual incidence rate in the range of 4-5% in general populations and up to 6% in patients aged 75 years and over. Surgical aortic valve replacement (SAVR) was previously the only option available to patients with symptomatic, severe aortic stenosis. After the first-in-human transcatheter aortic valve implantation (TAVI) was performed by Alain Cribier in 2002, the treatment strategy for patients with symptomatic AS has been revolutionized. Since then, TAVI has grown exponentially, as a result of accruing evidence demonstrating safety and efficacy, and reduced invasiveness compared with SAVR. TAVI devices are continuously expanding to include several valve design options. As this strategy is continuously evolving to treat younger patients and lower-risk populations, aside from the long-term durability of the valve systems, procedural safety will become the focus of newer-generation devices. This book is a practical handbook devoted to the optimization of TAVI procedures, through a focused containment of complications. Through an integrated evaluation of the clinical status, imaging techniques and laboratory findings, the authors provide readers with clear messages on preventive and therapeutic recommendations.

"Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure that repairs the valve without removing the old, damaged valve. TAVR is reserved for those patients for whom an open heart surgery procedure is not an option due to age and overall health. Most of the patients that are good candidates for this procedure are over 70 years old. The TAVR programs are multi-disciplinary units with nurses at the front. The NPs and CNSs are responsible for setting up the programs and ensuring that the right candidates are chosen to participate by conducting patient screenings, gather medical records, schedule pre-diagnostic testing and setting up appointments, and communicating with all physicians. Over 200,000 procedures have been performed in the first decade of innovation. TAVR is poised to become the standard of care for most patients with aortic stenosis. The maturity of the technology is not matched with the availability of practical tools for allied health professionals working in this complex field. The authors are international leaders in TAVR program development and have the collective expertise to fill this gap. The primary objective for this text is to serve as the "go-to" resource for TAVR programs development and organization of the clinical evaluation pathway. To date, this information has been conveyed by the author group through conference proceedings, didactic industry-sponsored sessions or social networking on a limited basis. The author team has received repeated requests for the information conveyed. This reference text will be highly sought after by clinicians and industry partners. It will become the recognized standard resource across centers"--Provided by publisher.

Aortic Valve Transcatheter Intervention Calcific aortic stenosis (AS) is the most common heart valve anomaly, with a largely age-dependent prevalence, a calculated annual incidence rate in the range of 4-5% in general populations and up to 6% in patients aged 75 years and over. Surgical aortic valve replacement (SAVR) was previously the only option available to patients with symptomatic, severe aortic stenosis. After the first-in-human transcatheter aortic valve implantation (TAVI) was performed by Alain Cribier in 2002, the treatment strategy for patients with symptomatic AS has been revolutionized. Since then, TAVI has grown exponentially, as a result of accruing evidence demonstrating safety and efficacy, and reduced invasiveness compared with SAVR. TAVI devices are continuously expanding to include several valve design options. As this strategy is continuously evolving to treat younger patients and lower-risk populations, aside from the long-term durability of the valve systems, procedural safety will become the focus of newer-generation devices. This book is a practical handbook devoted to the optimization of TAVI procedures, through a focused containment of complications. Through an integrated evaluation of the clinical status, imaging techniques and laboratory findings, the authors provide readers with clear messages on preventive and therapeutic recommendations.

This book provides comprehensive information on transcatheter aortic valve implantation (TAVI), which was introduced for the treatment of aortic valve disease less than two decades ago. It explains how TAVI has delivered satisfactory results even in high and intermediate risk patients and outlines how it continues to evolve, thus requiring awareness of state of the art approaches to indication, risk stratification, device choice, procedure, and follow-up. In addition, it reports on the complex and multidisciplinary approach needed to maximize the efficacy, safety, and appropriateness of TAVI, providing detailed clinical, interventional and surgical perspectives focusing on the development of this cardiovascular intervention. Starting with the history of TAVI, addressing the interventional anatomy of aortic valve disease, and reporting on the expert authors’ day-to-day experiences, this highly informative book offers an essential update for all cardiologists and surgeons interested in transcatheter aortic valve implantation, as well as any clinician, decision-maker and stakeholder involved in patient selection, procedural management, and follow-up.